Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Chronic alcohol exposure modifies endocannabinoid levels in different brain regions, while pharmacological targeting of the endocannabinoid system has been reported to influence ethanol intake in laboratory animals. The present study was aimed at evaluating the pattern of changes of endocannabinoids and their receptors, with emphasis on reward‐related brain areas, in Wistar rats subjected to consecutive phases of alcoholization, alcohol deprivation (abstinence), and voluntary consumption of alcohol (relapse). We observed that, in the limbic forebrain, anandamide (AEA) and 2‐arachidonoylglycerol (2‐AG) contents increased after 7 days of alcoholization, then to dramatically decrease after 48 h of alcohol deprivation and, in the case of 2‐AG, to further decrease when rats were allowed to relapse to alcohol consumption. By contrast, in the midbrain, there was a marked reduction in AEA, but not 2‐AG, content, after alcoholization. This decrease was not affected during alcohol abstinence, but both AEA and 2‐AG contents were then significantly reduced when rats were allowed to relapse to alcohol consumption. Based on these data, we examined whether pharmacological activation/blockade of endocannabinoid transmission might influence ethanol intake in rats allowed to relapse to alcohol consumption after subsequent periods of alcoholization and alcohol deprivation. Treatment with either Δ 9‐tetrahydrocannabinol or CP55,940, two cannabinoid agonists, reduced both total liquid and ethanol intake but did not affect ethanol preference. Treatment with SR141716, a selective cannabinoid CB 1 receptor antagonist, also produced a significant reduction in both total liquid and ethanol intake without affecting ethanol preference. Accordingly, none of these effects on ethanol intake were accompanied by changes in dopamine and GABA in limbic structures. In summary, the levels of endocannabinoids underwent significant changes in reward‐related areas during alcoholization, alcohol deprivation, and relapse, showing the lowest values in this latter phase. Treatment with cannabinoid agonists or a selective CB 1 receptor antagonist resulted in a reduction of ethanol intake by rats allowed to relapse to alcohol consumption after periods of alcoholization and alcohol deprivation, but these effects did not appear to be due to changes in neurobiological substrates currently involved in alcohol reinforcement/relapse. British Journal of Pharmacology (2004) 143, 455–464. doi:10.1038/sj.bjp.0705963
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., Watson, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 1×
“They were used to analyze CB1 receptor binding according to the autoradiographic method described by Herkenham et al. (1991), using 10nM [3H]-CP-55,940 (Du Pont NEN) as radioactive ligand.”
MethodKirkham, T. C., Williams, C. M., Fezza, F., & Marzo, V. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704767 · Cited by 788
Self-citationEndocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
Animal Models of Alcoholism: Neurobiology of High Alcohol-Drinking Behavior in Rodents
McBride, W. J., & Li, T.-K. (1998) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v12.i4.40 · Cited by 600
Arnone, M., Maruani, J., Chaperon, F., Thiébot, M.-H., Poncelet, M., Soubrié, P., & Fur, G. L. (1997) · Psychopharmacology · doi:10.1007/s002130050326 · Cited by 594
Research works printed but not linked: 2
- 10.1111/j.1530-0277.2001.tb02209.x · doi:10.1111/j.1530-0277.2001.tb02209.x · Paper page
- 10.1111/j.1530-0277.2001.tb02353.x · doi:10.1111/j.1530-0277.2001.tb02353.x · Paper page
Cited by
Neuropharmacology of alcohol addiction
Vengeliene, V, Bilbao, A., Molander, A., & Spanagel, R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.30 · Cited by 571
SUGIURA, T., KISHIMOTO, S., OKA, S., & GOKOH, M. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.003 · Cited by 352
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Caillé, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D. G., & Parsons, L. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-06.2007 · Cited by 280
“Consistent with this theory is evidence that repeated noncontingent drug administration results in altered levels of the endogenous cannabinoids N-arachidonoylethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) in postmortem rat brain tissue (Gonzalez et al., 2004; Vigano et al., 2004).”
BackgroundResultEndocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 180
Zoerner, A. A., Gutzki, F.-M., Batkai, S., May, M., Rakers, C., Engeli, S., Jordan, J., & Tsikas, D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.08.004 · Cited by 176
N-acylethanolamines, anandamide and food intake
Hansen, H. S., & Diep, T. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.024 · Cited by 164
Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference
Hansson, A. C., Bermúdez-Silva, F. J., Malinen, H., Hyytiä, P., Sanchez-Vera, I., Rimondini, R., Rodriguez de Fonseca, F., Kunos, G., Sommer, W. H., & Heilig, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301034 · Cited by 163
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls
Buczynski, M. W., & Parsons, L. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00787.x · Cited by 158
Basavarajappa, B. S., Yalamanchili, R., Cravatt, B. F., Cooper, T. B., & Hungund, B. L. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.005 · Cited by 131
Basavarajappa, B. S. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866910 · Cited by 129
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Toczek, M., & Malinowska, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.054 · Cited by 117
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 117
Vinod, K. Y., Kassir, S. A., Hungund, B. L., Cooper, T. B., Mann, J. J., & Arango, V. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.013 · Cited by 113
Panlilio, L. V., Justinova, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 108
Alpár, A., Marzo, V. D., & Harkany, T. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.009 · Cited by 101
Filip, M., Gołda, A., Zaniewska, M., McCreary, A. C., Nowak, E., Kolasiewicz, W., & Przegaliński, E. (2006) · PubMed · Cited by 99
Rubio, M., McHugh, D., Fernández‐Ruíz, J., Bradshaw, H. B., & Walker, J. M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.052 · Cited by 85
Serrano, A., Rivera, P., Pavon, F. J., Decara, J., Suárez, J., Rodriguez de Fonseca, F., & Parsons, L. H. (2012) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01686.x · Cited by 83
The anandamide transport inhibitor AM404 reduces ethanol self‐administration
Cippitelli, A., Bilbao, A., Gorriti, M. Á., Navarro, M. A., Massi, M., Piomelli, D., Ciccocioppo, R., & de Fonseca, F. R. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05665.x · Cited by 72
The Endocannabinoid Anandamide Inhibits the Function of α4β2 Nicotinic Acetylcholine Receptors
Spivak, C. E., Lupica, C. R., & Öz, M. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.036939 · Cited by 69
Basavarajappa, B. S. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707781387920 · Cited by 67
Roles for the endocannabinoid system in ethanol-motivated behavior
Henderson-Redmond, A. N., Guindon, J., & Morgan, D. J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.011 · Cited by 64
Alvarez‐Jaimes, L., Stouffer, D. G., & Parsons, L. H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06301.x · Cited by 62
Melis, M., Sagheddu, C., De Felice, M., Casti, A., Madeddu, C., Spiga, S., Muntoni, A. L., Mackie, K., Marsicano, G., Colombo, G., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1844-14.2014 · Cited by 58
Sanchez-Marin, L., Pavon, F. J., Decara, J., Suarez, J., Gavito, A., Castilla-Ortega, E., Rodriguez de Fonseca, F., & Serrano, A. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00015 · Cited by 55
Ceccarini, J., Casteels, C., Koole, M. J. B., Bormans, G. M., & Laere, K. V. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2456-1 · Cited by 54
Endocannabinoid regulation of relapse mechanisms
Fattore, L., Fadda, P., & Fratta, W. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.004 · Cited by 52
Rubio, M., Fernández‐Ruíz, J., de Miguel, R., Maestro, B., Walker, J. M., & Ramos, J. A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.005 · Cited by 50
Self-citationRubio, M., de Miguel, R., Fernández‐Ruíz, J., Gutiérrez-López, D., Carai, M. A. M., & Ramos, J. A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.004 · Cited by 48
Self-citationLallemand, F., & Witte, P. D. (2006) · Alcohol · doi:10.1016/j.alcohol.2006.08.001 · Cited by 47
Melis, M., Pillolla, G., Perra, S., Colombo, G., Muntoni, A. L., & Pistis, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1309-2 · Cited by 39
García‐Marchena, N., Pavón, F. J., Pastor, A., Araos, P. F., Pedraz, M., Romero‐Sanchiz, P., Calado, M., Suárez, J., Castilla‐Ortega, E., Orío, L., et al. (2016) · Addiction Biology · doi:10.1111/adb.12408 · Cited by 38
Robinson, S. L., Alexander, N. J., Bluett, R. J., Patel, S., & McCool, B. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.005 · Cited by 36
Iwasaki, S., Ishiguro, H., Higuchi, S., Onaivi, E. S., & Arinami, T. (2007) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32809913d8 · Cited by 35
Butt, C. M., Alptekin, A., Shippenberg, T. S., & Öz, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05225.x · Cited by 32
Stuart, J. M., Paris, J. J., Frye, C. A., & Bradshaw, H. B. (2013) · International Journal of Endocrinology · doi:10.1155/2013/436252 · Cited by 32
Malinen, H., Lehtonen, M., & Hyytiä, P. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01008.x · Cited by 31
Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes
Serrano, A., & Natividad, L. A. (2022) · Alcohol research · doi:10.35946/arcr.v42.1.09 · Cited by 30
Erdozain, A. M., & Callado, L. F. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.02.003 · Cited by 30
Rubio, M., Villain, H., Docagne, F., Roussel, B. D., Ramos, J. A., Vivien, D., Fernández‐Ruíz, J., & Ali, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023690 · Cited by 29
Self-citationNeuroinflammation as a possible link between cannabinoids and addiction
Rodrigues, L. C. M., Gobira, P. H., de Oliveira, A. C., Pelição, R., Teixeira, A. L., Moreira, F. A., & Campos, A. C. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.24 · Cited by 29
Frontera, J. L., Pini, V. M. G., Messore, F., & Brusco, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.018 · Cited by 28
Moranta, D., Esteban, S., & García-Sevilla, J. A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.061 · Cited by 27
Feuerecker, M., Hauer, D., Gresset, T., Lassas, S., Kaufmann, I., Vogeser, M., Briegel, J., Hornuß, C., Choukèr, A., & Schelling, G. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/agr162 · Cited by 26
Endogenous cannabinoids in post-mortem brains of Cloninger type 1 and 2 alcoholics
Lehtonen, M., Storvik, M., Tupala, E., Hyytiä, P., Tiihonen, J., & Callaway, J. C. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.008 · Cited by 25
Mannucci, C., Navarra, M., Pieratti, A., Russo, G. A., Caputi, A. P., & Calapai, G. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq242 · Cited by 25
Öz, M., Jackson, S. N., Woods, A. S., Morales, M., & Zhang, L. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081315 · Cited by 25
Gutiérrez‐López, M. D., Llopis, N., Feng, S., Barrett, D. A., O’Shea, E., & Colado, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00720.x · Cited by 24
Henricks, A. M., Berger, A. L., Lugo, J. M., Baxter-Potter, L. N., Bieniasz, K. V., Craft, R. M., & McLaughlin, R. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.032 · Cited by 23
Laere, K. V. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0505-3 · Cited by 22
Best, L. M., Hendershot, C. S., Buckman, J. F., Jagasar, S., McPhee, M. D., Muzumdar, N., Tyndale, R. F., Houle, S., Logan, R., Sanches, M., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.022 · Cited by 21
Minowa, S., Ishihara, S., Tsuchiya, S., Horie, S., & Murayama, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.048 · Cited by 19
Dong, X., Li, L., Ye, Y., Zhang, D., Zheng, L., Jiang, Y., & Shen, M. (2018) · Biomedical Chromatography · doi:10.1002/bmc.4439 · Cited by 19
Rezayof, A., Ghandipour, M., & Nazari-Serenjeh, F. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.08.009 · Cited by 17
Spigelman, I. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c5 · Cited by 17
Shared mechanisms of alcohol and other drugs.
(2008) · Europe PMC (PubMed Central) · Cited by 16
Sanchez-Marin, L., Gavito, A. L., Decara, J., Pastor, A., Castilla-Ortega, E., Suarez, J., de la Torre, R., Pavon, F. J., Rodriguez de Fonseca, F., & Serrano, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.012 · Cited by 16
Vázquez-León, P., Miranda-Páez, A., Calvillo-Robledo, A., & Marichal‐Cancino, B. A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136218 · Cited by 13
- Role of the Endocannabinoid System in the Neurobiology of Suicide
Dwivedi, Y. (2012) · CRC Press eBooks · doi:10.1201/b12215-11 · Cited by 12
PET Imaging of Endocannabinoid System
Horti, A. G., Raymont, V., & Terry, G. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_11 · Cited by 12
Role of the Endocannabinoid System in the Neurobiology of Suicide
Vinod, K. (2012) · Frontiers in neuroscience · doi:10.1201/b12215-6 · Cited by 10
Cannabinoid effects on behaviors maintained by ethanol or food: a within-subjects comparison
Ginsburg, B. C., & Lamb, R. J. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200605000-00006 · Cited by 10
Kärkkäinen, O. K., Lehtonen, M., Laukkanen, V., Tupala, E., Hyytiä, P., Kautiainen, H., Tiihonen, J., Callaway, J. C., & Storvik, M. (2013) · Alcohol · doi:10.1016/j.alcohol.2013.05.003 · Cited by 10
N-oleoyl glycine and N-oleoyl alanine attenuate alcohol self-administration and preference in mice
Shahen-Zoabi, S., Smoum, R., Bingor, A., Grad, E., Nemirovski, A., Shekh‐Ahmad, T., Mechoulam, R., & Yaka, R. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02574-4 · Cited by 9
Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology
Laredo, S. A., Marrs, W., & Parsons, L. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_10 · Cited by 8
Modulation of morphine and alcohol motor stimulant effects by cannabinoid receptors ligands
Hagues, G., Costentin, J., & Duterte‐Boucher, D. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.001 · Cited by 8
Castelli, V., Tringali, G., Bartolomeo, M. D., Lavanco, G., D’Addario, C., Palivec, P., Kuchař, M., Cannizzaro, C., & Brancato, A. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261420097 · Cited by 6
Implicación del sistema cannabinoide endógeno en el alcoholismo
Erdozain, A. M., Meana, J. J., & Callado, L. F. (2009) · Trastornos Adictivos · doi:10.1016/s1575-0973(09)72056-2 · Cited by 6
Sangiamo, D. T., Weingarten, M. J., Nelson, N. G., Choi, C. Y., Das, A., & Liang, N. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114587 · Cited by 6
PET Imaging of the Endocannabinoid System
Terry, G. E., Raymont, V., & Horti, A. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_12 · Cited by 5
Cannabinoid-Alcohol Interactions
Natividad, L. A., Maccioni, P., Parsons, L. H., & Colombo, G. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_14 · Cited by 5
Brain Imaging of Cannabinoid Receptors
Casteels, C., Bormans, G. M., & Laere, K. V. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00003-8 · Cited by 4
Moranta, D. (2005) · Biblioteca Digital de les Illes Balears (Universitat de les Illes Balears) · Cited by 4
Cannabinoids and the Neural Actions of Alcohol
Pava, M. J., & Lovinger, D. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405941-2.00014-6 · Cited by 2
Cannabinoids and drug addiction
Luca, M. A. D., & Fattore, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00012-6 · Cited by 2
Sánchez-Marín, L. (2023) · Repositorio Institucional de la Universidad de Málaga (University of Málaga) · Cited by 1
PAPEL DEL SISTEMA ENDOCANNABINOIDE EN EL ALCOHOLISMO: ESTUDIO EN MODELOS ANIMALES
Sánchez-Vera, I. (2007) · Cited by 1
Estudio de los efectos del tratamiento con antidepresivos sobre el consumo de alcohol
Garcia, A. B. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Marcadores biológicos en trastornos por uso de alcohol y comorbilidad psiquiátrica asociada
García‐Marchena, N. (2017) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 1
Best, L. M. (2022) · TSpace (University of Toronto) · Cited by 1
Kärkkäinen, O. K. (2016) · UEF eRepo (University of Eastern Finland) · doi:10.13140/rg.2.1.3236.3929 · Cited by 1
Papel del sistema cannabinoide endógeno en el alcoholismo: implicaciones fisiológicas y terapéuticas
Rubio, M. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
(2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816793-9.00001-3
Liput, D. J. (2013) · UKnowledge (University of Kentucky)
Chen, R. (2025) · TSpace (University of Toronto)
Drennan, M. L. A., Hetelekides, E. M., & Karoly, H. C. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-026-00484-y
Robinson, S. L. (2015) · WakeSpace Scholarship (Wake Forest University)
Participação dos receptores canabinóides cerebrais na tolerância rápida e aguda do álcool
Carvalho, J. I. L. M. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ceccarini, J. (2012) · Lirias (KU Leuven)
Electroacupuncture effects over CB1 cannabinoid receptor in ethanol withdrawal mice
Escosteguy-Neto, J. C. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- González, S., Valenti, M., de Miguel, R., Fezza, F., Fernández‐Ruiz, J., Di Marzo, V., & Ramos, J. A.
- Affiliations
- Universidad Complutense de Madrid (ES)
- Istituto di Chimica Biomolecolare (IT)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-10
- Volume
- 143
- Issue
- 4
- Pages
- 455-464
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1575417
- OpenAlex
- W2095302802
- Cited by
- 79
- References
- 61
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 4
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- endocannabinoid system, alcohol relapse, chronic ethanol exposure, alcohol deprivation, anandamide, 2-arachidonoylglycerol, CB1 receptor, delta-9-tetrahydrocannabinol, CP55,940, SR141716, ethanol consumption, ethanol preference, brain reward system, limbic forebrain, midbrain, dopamine, GABA
- MeSH terms
- Ethanol, Alcoholism, Animals, Brain, Male, Reward, Rats, Wistar, Receptor, Cannabinoid, CB1, Rats, Secondary Prevention, Cannabinoid Receptor Modulators, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.